Hepatocellular carcinoma: New and emerging risks

被引:22
作者
Sherman, Morris [1 ,2 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON M5N 2N2, Canada
[2] Univ Hlth Network, Toronto, ON M5N 2N2, Canada
关键词
Cirrhosis; Hepatitis B; Hepatitis C; Hepatocellular carcinoma;
D O I
10.1016/S1590-8658(10)60508-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The underlying liver diseases that put patients at risk for the development of hepatocellular carcinoma (HCC) are well known. However, it is equally well known that not all patients with these conditions will develop HCC. Therefore within the disease groups (hepatitis B, cirrhosis, etc.,) there are other factors that indicate greater or lesser risk. Some markers of risk are common to all causes of HCC, such as cellular dysplasia, advancing age and male gender. Others factors are specific to individual diseases. This has been well established for hepatitis B in which viral load, genotype and antigen status are major contributors to increased risk of HCC. For both hepatitis B and hepatitis C attempts have been made to identify those individuals at greatest risk using data from large cohort studies. In addition to the common causes of liver disease that are recognized to be causes of HCC non-alcoholic fatty liver disease and possibly diabetes are newly emerging risk factors. (C) 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S215 / S222
页数:8
相关论文
共 79 条
[1]  
Anthony PP, 1987, HEPATOLOGY, V7, P394
[2]   EMERGENCE OF MALIGNANT LESIONS WITHIN AN ADENOMATOUS HYPERPLASTIC NODULE IN A CIRRHOTIC LIVER - OBSERVATIONS IN 5 CASES [J].
ARAKAWA, M ;
KAGE, M ;
SUGIHARA, S ;
NAKASHIMA, T ;
SUENAGA, M ;
OKUDA, K .
GASTROENTEROLOGY, 1986, 91 (01) :198-208
[3]   INCREASED RISK OF HEPATOCELLULAR-CARCINOMA DEVELOPMENT IN PATIENTS WITH CIRRHOSIS AND WITH HIGH HEPATOCELLULAR PROLIFERATION [J].
BALLARDINI, G ;
GROFF, P ;
ZOLI, M ;
BIANCHI, G ;
GIOSTRA, F ;
FRANCESCONI, R ;
LENZI, M ;
ZAULI, D ;
CASSANI, F ;
BIANCHI, F .
JOURNAL OF HEPATOLOGY, 1994, 20 (02) :218-222
[4]   Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma [J].
Bañares, R ;
Núñez, O ;
Escudero, M ;
Fernández, C ;
Vaquero, J ;
Beceiro, I ;
Echenagusía, A ;
Clemente, G ;
Santos, L .
HEPATOLOGY, 2005, 41 (03) :566-571
[5]  
BEASLEY RP, 1981, LANCET, V2, P1129
[6]  
Borzio M, 1998, J CLIN PATHOL-MOL PA, V51, P96
[7]   LIVER-CELL DYSPLASIA IS A MAJOR RISK FACTOR FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A PROSPECTIVE-STUDY [J].
BORZIO, M ;
BRUNO, S ;
RONCALLI, M ;
MELS, GC ;
RAMELLA, G ;
BORZIO, F ;
LEANDRO, G ;
SERVIDA, E ;
PODDA, M .
GASTROENTEROLOGY, 1995, 108 (03) :812-817
[8]  
BRUIX J, 1989, LANCET, V2, P1004
[9]   Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[10]  
Caballería L, 2001, AM J GASTROENTEROL, V96, P1160